Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 8/20 | 0.39 |
| ▸ | CTSK | P43235 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8261408 | 0.90 | SMN1; SMN2 (0.50) | SMN1; SMN2LMNAL3MBTL1ALDH1A1POLB | |
| SCHEMBL10835144 | 0.83 | SMN1; SMN2 (0.50) | SMN1; SMN2LMNAL3MBTL1ALDH1A1POLB | |
| SCHEMBL28259387 | 0.80 | SMN1; SMN2 (0.49) | SMN1; SMN2LMNAL3MBTL1ALDH1A1POLB | |
| SCHEMBL4990259 | 0.79 | SMN1; SMN2 (0.48) | SMN1; SMN2LMNAL3MBTL1ALDH1A1POLB | |
| SCHEMBL10834757 | 0.78 | SMN1; SMN2 (0.50) | SMN1; SMN2LMNAL3MBTL1ALDH1A1POLB | |
| SCHEMBL1994862 | 0.78 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNAL3MBTL1ALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL5593739 | 0.78 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNAL3MBTL1ALDH1A1POLB | |
| SCHEMBL6656395 | 0.78 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNAL3MBTL1ALDH1A1POLB | |
| SCHEMBL6656396 | 0.78 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNAL3MBTL1ALDH1A1POLB | |
| SCHEMBL1994865 | 0.78 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNAL3MBTL1ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3489215-B1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | KANEKA CORP (JP) | 2023-12-20 | — | — | EP | claimed |
| CN-109689611-B | Method for producing organic compound | 株式会社钟化 | 2021-09-28 | — | — | CN | claimed |
| US-10781193-B2 | Process for producing organic compound | KANEKA CORPORATION (JP) | 2020-09-22 | — | — | US | claimed |
| EP-3489215-A1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | Kaneka Corporation (JP) | 2019-05-29 | — | — | EP | claimed |
| US-20190144404-A1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | KANEKA CORPORATION (JP) | 2019-05-16 | — | — | US | claimed |
| EP-3489215-B1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | KANEKA CORP (JP) | 2023-12-20 | — | — | EP | disclosed |
| CN-111051287-B | Method for producing organic compound | 株式会社钟化 | 2023-10-03 | — | — | CN | disclosed |
| CN-109689611-B | Method for producing organic compound | 株式会社钟化 | 2021-09-28 | — | — | CN | disclosed |
| US-10781193-B2 | Process for producing organic compound | KANEKA CORPORATION (JP) | 2020-09-22 | — | — | US | disclosed |
| CN-111051287-A | Method for producing organic compound | 株式会社钟化 | 2020-04-21 | — | — | CN | disclosed |
| EP-3489215-A1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | Kaneka Corporation (JP) | 2019-05-29 | — | — | EP | disclosed |
| US-20190144404-A1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | KANEKA CORPORATION (JP) | 2019-05-16 | — | — | US | disclosed |
| JP-2004210660-A | METHOD FOR PRODUCING BENZYL (2S,3aR,7aS)-1-{(S)-N-[(S)-1-ETHOXYCARBONYL-3-PHENYLPROPYL]ALANYL}HEXAHYDRO-2-INDOLINECARBOXYLATE | OHARA YAKUHIN KOGYO KK | 2004-07-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190144404-A1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | TTL, DCLK1, CTH | SMN1; SMN2 4855/4885LMNA 4879/4885L3MBTL1 2483/4885 |
| US-10781193-B2 | Process for producing organic compound | TTL, DCLK1, CTH | SMN1; SMN2 4855/4885LMNA 4879/4885L3MBTL1 2483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.